Morgan Stanley Upgrades Sinovac Biotech (SVA) to Overweight

March 20, 2014 8:59 AM EDT Send to a Friend
Morgan Stanley upgraded Sinovac Biotech (NASDAQ: SVA) from Equalweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login